Bayesian multistudy factor analysis for high-throughput biological data
暂无分享,去创建一个
Lorenzo Trippa | Giovanni Parmigiani | Ruggero Bellio | Roberta De Vito | G. Parmigiani | L. Trippa | R. Bellio | R. D. Vito
[1] T. Barrette,et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.
[2] Lorenzo Trippa,et al. Multi‐study factor analysis , 2016, Biometrics.
[3] David Causeur,et al. A factor model to analyze heterogeneity in gene expression , 2010, BMC Bioinformatics.
[4] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[5] Peter Regitnig,et al. Genomic index of sensitivity to endocrine therapy for breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] G Leclercq,et al. About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer , 2004, Molecular and Cellular Endocrinology.
[7] G. Church,et al. Systematic management and analysis of yeast gene expression data. , 2000, Genome research.
[8] Christopher D. Brown,et al. A latent factor model with a mixture of sparse and dense factors to model gene expression data with confounding effects , 2013, 1310.4792.
[9] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[10] C. Planey,et al. CoINcIDE: A framework for discovery of patient subtypes across multiple datasets , 2016, Genome Medicine.
[11] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[12] C. Vidal,et al. Reproducibility of data-driven dietary patterns in two groups of adult Spanish women from different studies , 2016, British Journal of Nutrition.
[13] H. Kaiser. The varimax criterion for analytic rotation in factor analysis , 1958 .
[14] H. Kölbl,et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. , 2008, Cancer research.
[15] Age K. Smilde,et al. Real-life metabolomics data analysis : how to deal with complex data ? , 2010 .
[16] V. Theodorou,et al. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility , 2013, Genome research.
[17] Olga G. Troyanskaya,et al. A scalable method for integration and functional analysis of multiple microarray datasets , 2006, Bioinform..
[18] Stephen P. Fox,et al. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells , 2013, Nucleic acids research.
[19] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[20] I. Ellis,et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer , 2011, Nature.
[21] Michael A. West,et al. BAYESIAN MODEL ASSESSMENT IN FACTOR ANALYSIS , 2004 .
[22] K. Keyomarsi,et al. Redundant cyclin overexpression and gene amplification in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. George,et al. Fast Bayesian Factor Analysis via Automatic Rotations to Sparsity , 2016 .
[24] Sayan Mukherjee,et al. Dissecting High-Dimensional Phenotypes with Bayesian Sparse Factor Analysis of Genetic Covariance Matrices , 2012, Genetics.
[25] R. Schiff,et al. Estrogen receptor: current understanding of its activation and modulation. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] Daniel R. Salomon,et al. Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.
[27] J. Geweke,et al. Measuring the pricing error of the arbitrage pricing theory , 1996 .
[28] Edith M. Ross,et al. Regulators of genetic risk of breast cancer identified by integrative network analysis , 2015, Nature Genetics.
[29] A. Charchanti,et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. , 2002, European journal of cancer.
[30] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Khatri,et al. A systems biology approach for pathway level analysis. , 2007, Genome research.
[32] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[33] C. Sander,et al. Collection, integration and analysis of cancer genomic profiles: from data to insight. , 2014, Current opinion in genetics & development.
[34] Giovanni Parmigiani,et al. Integrating diverse genomic data using gene sets , 2011, Genome Biology.
[35] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[36] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[37] H. Morgenstern,et al. Nutrient-based dietary patterns and the risk of head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[39] C. Huttenhower,et al. Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. , 2014, Journal of the National Cancer Institute.
[40] Chloé Friguet,et al. A Factor Model Approach to Multiple Testing Under Dependence , 2009 .
[41] Ian C. McDowell,et al. Differential gene co-expression networks via Bayesian biclustering models , 2014, 1411.1997.
[42] Christian Aßmann,et al. Bayesian analysis of static and dynamic factor models: An ex-post approach towards the rotation problem , 2016 .
[43] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[44] Stefano Monti,et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] Jean Thioulouse,et al. CO‐INERTIA ANALYSIS AND THE LINKING OF ECOLOGICAL DATA TABLES , 2003 .
[48] Terence P. Speed,et al. Unifying Gene Expression Measures from Multiple Platforms Using Factor Analysis , 2011, PloS one.
[49] David Chen,et al. ESR1 ligand binding domain mutations in hormone-resistant breast cancer , 2013, Nature Genetics.
[50] Kathleen F. Kerr,et al. Extended analysis of benchmark datasets for Agilent two-color microarrays , 2007, BMC Bioinformatics.
[51] M. Hung,et al. β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .
[52] H. Abdi,et al. Multiple factor analysis: principal component analysis for multitable and multiblock data sets , 2013 .
[53] V. Jordan,et al. Chemoprevention of breast cancer with selective oestrogen-receptor modulators , 2007, Nature Reviews Cancer.
[54] Anne-Laure Boulesteix,et al. Cross-study validation for the assessment of prediction algorithms , 2014, Bioinform..
[55] H. Ishwaran,et al. Lung metastasis genes couple breast tumor size and metastatic spread , 2007, Proceedings of the National Academy of Sciences.
[56] J. Bergh,et al. Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series , 2007, Clinical Cancer Research.
[57] M. West,et al. High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics , 2008, Journal of the American Statistical Association.
[58] J. Hasty,et al. Reverse engineering gene networks: Integrating genetic perturbations with dynamical modeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[59] Snigdhansu Chatterjee,et al. Procrustes Problems , 2005, Technometrics.
[60] Javed Siddiqui,et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer , 2013, Nature Genetics.
[61] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[62] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[63] Aedín C. Culhane,et al. A multivariate approach to the integration of multi-omics datasets , 2014, BMC Bioinformatics.
[64] Elizabeth Garrett-Mayer,et al. Cross-study validation and combined analysis of gene expression microarray data. , 2007, Biostatistics.
[65] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] Sayan Mukherjee,et al. Bayesian group latent factor analysis with structured sparsity , 2014, 1411.2698.
[67] N. Rosen,et al. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 , 2002, Oncogene.
[68] Soonmyung Paik,et al. Use of archived specimens in evaluation of prognostic and predictive biomarkers. , 2009, Journal of the National Cancer Institute.
[69] John Quackenbush,et al. A three-gene model to robustly identify breast cancer molecular subtypes. , 2012, Journal of the National Cancer Institute.
[70] Funda Meric-Bernstam,et al. Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes , 2013, Clinical Cancer Research.
[71] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[72] Chuan Gao,et al. Context Specific and Differential Gene Co-expression Networks via Bayesian Biclustering , 2016, PLoS Comput. Biol..
[73] D. Dunson,et al. Sparse Bayesian infinite factor models. , 2011, Biometrika.
[74] Brooke L. Fridley,et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.
[75] Julien Textoris,et al. Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells , 2009, PloS one.